Coherus Biosciences | CHRS - Assets

Coherus Biosciences reported $480.85M in Assets for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Assets Change
Acadia Pharmaceuticals ACAD:US USD 587.81M 14.68M
Akebia Therapeutics AKBA:US USD 351.83M 84.06M
ALKERMES ALKS:US USD 1.96B 22.08M
Alnylam Pharmaceuticals ALNY:US USD 3.55B 11.1M
Amarin AMRN:US USD 908.3M 64.93M
Amgen AMGN:US USD 65.12B 1.42B
Baxter International BAX:US USD 28.29B 322M
Biogen BIIB:US USD 24.55B 300.1M
Biomarin Pharmaceutical BMRN:US USD 6.38B 111.03M
Bluebird Bio BLUE:US USD 520.1M 53.49M
Coherus Biosciences CHRS:US USD 480.85M 70.06M
Endo International Ordinary Shares ENDP:US USD 6.01B 355.8M
Fujifilm 4901:JP JPY 4.15T 138B
Gilead Sciences GILD:US USD 63.17B 614M
Horizon Pharma HZNP:US USD 9.11B 86.75M
Ironwood Pharmaceuticals IRWD:US USD 1.1B 60.18M
JAZZ PHA JAZZ:US USD 10.84B 450.59M
Myriad Genetics MYGN:US USD 1.2B 13.3M
Pacira Pharmaceuticals PCRX:US USD 1.68B 53.16M
Perrigo Ordinary Shares PRGO:US USD 11.02B 339.8M
Ptc Therapeutics PTCT:US USD 1.71B 129.22M
Regeneron Pharmaceuticals REGN:US USD 29.21B 1.54B
Revance Therapeutics RVNC:US USD 581.9M 129.69M
Sarepta Therapeutics SRPT:US USD 3.13B 27.78M
Teva Pharmaceutical TEVA:IT USD 44.01B 246M
Vertex Pharmaceuticals VRTX:US USD 18.15B 1.44B
Xencor XNCR:US USD 846.27M 11M
Zoetis ZTS:US USD 14.92B 1.25B